Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation



Similar documents
Recent Updates on European Requirements and what QPs are expected to do

Guidance for Industry: Starting Material Supplier Management

Harmonizing Change Control Processes Globally

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

QUALITY RISK MANAGEMENT (QRM): A REVIEW

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Guidance for Industry: Quality Risk Management

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Guidance for Industry

QUALITY RISK MANAGEMENT

FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)


1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

COMMISSION DIRECTIVE 2003/94/EC

Quality Management System for Active pharmaceutical Ingredients manufacturers. Integrating GMP into ISO 9001

Annex 2. WHO guidelines on quality risk management. 1. Introduction Glossary Quality risk management process 70

The FDA recently announced a significant

Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements

Annex 9 Guide to good storage practices for pharmaceuticals 1

Library Guide: Pharmaceutical GMPs

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

Aseptic preparations, including TPN, for a limited number of patients

Extemporaneously Prepared Early Phase Clinical Trial Materials

Pharmaceutical Quality Management System: Current Concept

Industry Implications of Pharmaceutical Quality ICH Guidelines

Community Guide to Good Practice For Feed Additive and Premixture Operators

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

Guidance on Qualification of existing facilities, systems, equipment and utilities

RISK IDENTIFICATION,ASSESSMENT & MITIGATION TEMPLATE

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, Oct 2009

Hazard Analysis and Critical Control Points (HACCP) 1 Overview

The Quality System for Drugs in Germany

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Quality assurance of pharmaceuticals

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

Leila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

Draft guidance for registered pharmacies preparing unlicensed medicines

Annex 7 Guidelines on pre-approval inspections

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

Best Practice In A Change Management System

Good Manufacturing Practices: A Synopsis of Their Role and Rationale in Today's Pharmaceutical Marketplace for Tubing

GMP Training Course Quality Control October Lesley Graham Senior Inspector (UK)

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

LIBRARY GUIDE. Online Courses. March 2012

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations

Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

identify hazards, analyze or evaluate the risk associated with that hazard, and determine appropriate ways to eliminate or control the hazard.

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

GMP Pharma BV. Netherlands

EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

Workshop B Control Strategy

Quality Risk Management ICH Q9 & ISO Presented by Michael Kerr 11 th November 2011

PHARMACEUTICAL QUALITY SYSTEM Q10

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

Presented by Rosemarie Bell 24 April 2014

The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers

Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

What is necessary to provide good clinical data for a clinical trial?

How to implement a Quality Management System

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals

SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION

PROCEDURE FOR HANDLING RAPID ALERTS AND RECALLS ARISING FROM QUALITY DEFECTS

Guidance for Industry. Q10 Pharmaceutical Quality System

Auditing as a Component of a Pharmaceutical Quality System

Good Manufacturing Practices (GMP) for Pharmaceutical Excipients

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

NSF International Standard / American National Standard. NSF/IPEC/ANSI Good Manufacturing Practices (GMP) for Pharmaceutical Excipients

Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.

EFPIA Good Practice Revision 1, October 2014

UNICEF s Quality Assurance System for procurement of medicines

NRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL

Manufacturing Cellular Products for International Clinical Trials

Overview of Pre-Approval Inspections

Implementation of ANSI/AAMI/IEC Medical Device Software Lifecycle Processes.

Deviation and Out of Specification Handling

Media fills Periodic performance qualification (Re-Validation)

Guideline on good pharmacovigilance practices (GVP)

ICH guideline Q10 on pharmaceutical quality system

CONCEPT HEIDELBERG. Pharmaceutical Quality Training. Conferences. Services.

Staying Current in Cold Chain Management

Transcription:

Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation

Agenda Quality Assurance Quality Management System Quality Risk Management Validation Master Plan Introduction to group work 4

Quality Assurance Quality Assurance is a wide-ranging concept, which covers all matters, which individually or collectively influence the quality of a product It is the sum total of the organised arrangements made with the objective of ensuring that medical products are of the quality required for their intended use Ref : Eudralex part 1 Quality The quality of something can be determined by comparing a set of inherent characteristics with a set of requirements* Characteristics include Product quality (safety and efficacy) Compliance with regulatory requirements Allowing deliveries with acceptable costs of production *Ref : ISO 9000

Safety Quality Assurance Costs Compliance Safety Activities relates to prevention of adverse events and other drug related problems Efforts ultimately links to the protection of the patient On-going attention to the risk-benefit balance specific for the product Pharmocovigilence based on Risk Management Scientific knowledge and relevant experience required Any safety concern to be evaluated Detailed requirements for interactions with the authorities

Monitoring Safety in a hospital pharmacy Pharmacovigilance Investigations in relation to reported Adverse Effects (AE) Survey of relevant literature Data from clinical studies Handling of technical complaints Complaints not reported as adverse effects Surveillance of trends Trend-reporting of complaints and AE s Trend reporting of deviations Stability studies PQR Compliance Meeting the requirements of the current GMP as they relate to your products Include conformance to official requirements as Laws Guidelines and standards Pharmacopoeias Regulatory files (MA, SMF) Interpretations are done by the health authorities In general no differences between the pharmaceutical industry and hospital pharmacies In reality compliance is a moving target based on evaluation of risks and on-going negotiations regarding good enough Take benefit of your position

Compliance in a Hospital Pharmacy Rooted in the Quality Management System Adjustments as required For-cause dialogue with authorities Inspections Completed by national authorities Scheduled or for-cause Approaching requirements to the industry Increasing harmonization within Europe and world wide Internal audits Directive 2003/94/EC To be conducted on a regular basis To be documented Costs Effectiveness in production and continuous improvements in production and deliveries are also quality goals! In general increased product quality with decreased number of irregularities More patient value for the same money Quality work is also repeatedly arguing for doing the right the first time Early quality related efforts are important Cost/benefit analysis in Business Plans Investments may also include costs related to training and validation

Quality Management System To achieve the quality objective in a reliable manner there must be a comprehensively designed and correctly implemented system of Quality Assurance incorporating Good Manufacturing Practice and thus Quality Control. It should be fully documented and its effectiveness monitored The establishment and maintenance of a satisfactory system of Quality Assurance and the correct manufacture of medicinal products relies upon people Ref : Eudralex part 1 People Continuous training must be documented Appropriate to the duties assigned Include GMP and Hygiene programmes Specific training if hazardous materials Include all groups of personnel Also technical staff, cleaning workers etc. The person responsible for release of products must be different from the person responsible for production

System of Quality Assurance = Quality Management System (QMS) Incorporate the principles of GMP Quality Control Quality Risk Management Internal requirements and aspirations QMS /1 GMP Requirements include (among other things): Approved SOPs Validation of critical attributes Change Control Traceability of activities and materials Records providing the full history of each batch Any deviation investigated and documented

QMS/2 Quality Control Include (among other things): Sampling, inspection and testing GMP materials as well as finished products Validated test methods Environmental monitoring Reviewing of documentation for manufacturing processes Release by a Qualified Person QMS/3 Quality Risk Management An integral part of most QA related activities Key elements High lights potential harms to the patient Utilizing product and process understanding Insist on data Document considerations and decisions Prioritize efforts

Quality Risk Management Extensive applications. Ex. : Development of products and processes Environmental monitoring Change Control Deviations (release or not release) Validation VMP, Protocols The Validation Master Plan (VMP) The key elements of a validation programme should be clearly defined and documented in a VMP The VMP should be a summary document which is brief, concise and clear In large projects it may be necessary to create separate VMP s Ref. Eudralex annex 15

The VMP should contain data on at least the following Validation Policy *Summary of facilities, systems, equipment and processes to be validated *Organisational structure of validation activities Documentation format: the format to be used for protocols and reports Planning and scheduling Change control Reference to existing documents Ref. Eudralex annex 15 Introduction to Group Work Design a VMP based on risk evaluation

Quality Risk Management No one tool or set of tools is applicable to every situation in which a quality risk management procedure is used * *Ref: Eudralex Annex 20 Risk = S x O x D S = Severity of harm O = Probability of Occurrence D = Likelihood of Detection Low Medium High Severity Will for sure not cause harms 1 Unlikely to cause harms 3 May cause harms 5 Occurrence Detection A rare unusual event 1 Very high likelihood of detection 1 Occur from time to time 3 May be detected 3 Common/well known event 5 Will not be detected 5 Risk=SxOxD

Risk identification Critical quality attributes in relation to the product Purity - chemical and microbiological Homogeneity Quality of materials API, excipients, packaging materials, materials in contact Facilities, equipments and systems Classification? Risk of contamination or cross-contamination Dedicated? Open or closed? Processes Manual or automatic Imprints? Controls In process controls Test methods People Education and training SOPs Risk evaluation Calculate the risk-score for each critical parameter Rank the risk-scores Prioritize activities taking risk-scores into consideration Out put from the Quality Risk Management Process to be used for e.g. the Validation Master Plan

The tasks: Prepare a summary of facilities, equipment and processes to be validated Broad description of products and facilities E.g. dosage forms, locations, processes, major equipment, utilities and sterilisation methods Conclusions from Quality Risk Assessment Describe the structure of validation activities Grouping of validation activities E.g. equipment, facilities, HVAC, cleaning, CRS, personnel (media fills) Structure of documents (Validations Plans, protocols, reports) Planned sequence of activities Supporting slides

Definitions and Abbreviations 1. CRS Computer Related System 2. Harm Damage to health, including the damage that can occur from loss of product quality or availability 3. HVAC Heat, Ventilation and Air Conditioning 4. SOP Standard Operation Procedure. I.e. procedures, instructions, manufacturing formulae and specifications 5. VP Validation Plan. Collect a inter-related group of protocols Initiate Risk Management Process Risk Assessment Risk Identification Risk Analysis Risk Evaluation Risk Ma nagement tools Risk Control Risk Reduction Risk Acceptance unacceptable Risk Communication Risk Review Risk Communication acceptable Risk Acceptance Output / Results of the Risk Management Process Review Events